Silodosin

Product Name:Silodosin Name:(-)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide Synonyms:(-)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide;Silodosin;KAD 3213;KMD 3213;Urief;Silodosin API;Silodosin(Rapaflo);(-)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-tr CAS:160970-54-7 Molecular Formula:C25H32F3N3O4 Molecular Weight: 495.53 Assay:99% Apprence:White Powder Usage:Used for treatment of benign prostatic hyperplasia.

Storage:Be stored in a well-closed container at low temperature, keep away from moisture, heat and light. Pharmacology:Since Silodosin is a highly selective inhibitor of the α1A adrenergic receptor, it causes practically no orthostatic hypotension (in contrast to other α1blockers).

Silodosin is a medication for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate). Silodosin is an alpha-blocker. It works by relaxing muscles in the prostate and bladder, which helps to improve urine flow and reduce symptoms of BPH.